baber/WOPTO huggingface dataset:
Patent MA-41018-B2 (MA)
Title: Composition de fibre de verre haute performance, fibre de verre et matériau composite associés
Inventor: LIN ZHANG
IPC: C03C13/00
Filed: 2015-10-15
Abstract: La présente invention concerne une composition de fibre de verre haute performance, une fibre de verre et un matériau composite associés. La composition de fibre de verre comprend les composants suivants, en pourcentage en poids : 58 % à 62 % de sio2, 14 % à 18 % d'al2o3, 20 % à 24,5 % de cao+mgo, cao dépassant 14 %, 0,01 % à 0,4 % de li2o, moins de 2 % de na2o+k2o, moins de 3,5 % de tio2, moins de 1 % de fe2o3, moins de 1 % de f2, le rapport en pourcentage en poids de c1 = cao/mgo étant supérieur à 2 et inférieur ou égal à 2,6, et le rapport en pourcentage en poids c2=sio2/cao allant de 3,3 à 4,3. La composition peut remarquablement améliorer les performances mécaniques et la température du point de ramollissement de la fibre de verre, réduire la viscosité du verre à haute température, supprimer efficacement la tendance de cristallisation du verre, réduire la température de liquidus du verre, et est appropriée pour produire à grande échelle dans des fours à cuve.
Patent CS-207362-B2 (CS)
Title: Method of making the fittings or similar products and mould for injection casting for execution of the said method
Inventor: ANGER ANTON
IPC: B29C45/36
Filed: 1976-07-29
Abstract: 1496854 Injection moulding grooved articles ANTON ANGER MASCHINENBAU GmbH 22 July 1976 [29 July 1975 10 Oct 1975] 30573/76 Heading B5A A method of producing grooves in containers, ducting or sleeves 4 comprises introducing synthetic material into a mould 1 having a multi-part core 3, heating the material at least in the region where the groove is formed so that the material displays resiliency and withdrawing the part 7 of the core 3 axially of the latter whilst the material is resilient so that the groove is elastically deformed and then recovers its moulded shape. As shown, the grooved sleeve is injection moulded from PVC in a split mould 1 having a three part core 3, part 8 of the core defining the outer contour of the groove 5. To withdraw the parts 7, 8, part 8 is slid along the main body of the core 3 by a drive acting on a flange 15 until a stop 16 engages a stop 17 on part 7 to thereby withdraw the latter and hence flange 13 from groove 5 as the part 8 is further withdrawn. The part 7 may be provided with a shoulder 18 for supporting the moulding after withdrawal of the core part 7 until the moulding has cooled sufficiently. The part 7 and/or the part 8 may be provided with cartridge heaters 22. The part 7 may be provided with air outlets so that air may be introduced between the core and moulding to facilitate parting. The core parts may be held in engagement during moulding by either a semi-circular wedge 12 (see Fig. 1, not shown) or a hydraulic device 24 (Figs. 5, 6, not shown).
Patent CS-216938-B2 (CS)
Title: Method of making the derivatives of the 7 beta-aminothiazolylycetamido-3-cefem-4-carboxyl acid
Inventor: SCARTAZZINI RICCARDO
IPC: C07D501/22
Filed: 1979-07-06
Abstract: 1. A 7 beta-aminothiazolylacetamido-3-cephem-4-carboxylic acid compound of the formula  see diagramm : EP0008343,P9,F1  wherein R1 is hydrogen or an amino protective group, A is methylene substituted by methoxyimino and R2  is pivaloyloxymethyl, or a salt of such a compound containing a salt-forming group.
Patent JP-H0699470-B2 (JP)
IPC: C07J43/00
Filed: 1992-01-08
Abstract: The invention relates to a new process for the preparation of 21-hydroxy-20-keto-steroids from 17-(isocyano-sulfonylmethylene)-steroids whereby simultaneously an unsaturated bond is introduced between C16 and C17. Furthermore the invention relates to new intermediate compounds formed in this process nad their preparation and to the ultimately formed 21-hydroxy-20-keto-delta<1><6>-steroids, as far as these latter compounds are new.
Patent JP-3093802-B2 (JP)
IPC: A61J1/16
Filed: 1991-01-18
Granted: 2000-10-03
Abstract: An ampoule holder comprises a body part 1 and a head part 2 which are connected together by a pair of hinge strips 3 and a breakage link 4. A glass ampoule 7 is inserted, stem first, through an opening 6 in the base of the body portion 1. The body of the ampoule is forced past inwardly extending projections 8 until the lower end of the ampoule snaps past these projections and the shoulder at the top of the body of the ampoule 7 abuts against the curved hinge parts 3. The base of the ampoule will then be raised above the projections 8. The stem 10 of the ampoule is gripped within the head portion 2 of the holder by internal ribs or spines 11, so that the neck 9 of the ampoule is aligned with the breakage link 4. In order to achieve access to the contents of the ampoule the holder is gripped in two hands and pressure is applied to a finger grip surface 13 of the head portion of the holder so that the breakage link 4 is fractured and the stem 10 of the ampoule is broken off at the neck 9 whilst the head portion 2 is folded back by means of the hinge strips 3. <IMAGE>
Patent JP-H0543597-B2 (JP)
Inventor: FUBERUTO AIRITSUHI
IPC: B01F15/02
Filed: 1984-01-20
Abstract: Described is an apparatus for closing and continuously emptying the container of a processing machine by means of a closure cover (6-9) which is arranged in the bottom (1) of the container and which is driven so that it can be moved into and out of the emptying opening (2) in the bottom (1) of the container by way of a pivotal shaft (17) acting as a lifting means on a mounting means, for example a mounting arm (16), outside the container. In order to permit both coarse and fine adjustment of the discharge rate in operation and also closure of the container, without incurring high levels of capital investment and also with robust operating characteristics, the invention provides that the closure cover (6-9) has a controllable rotary drive means (11, 14, 15), the pivotal shaft (17) acting as the lifting means is connected to a control drive means (21) for precise adjustment of the inclination of the mounting arm (16) and that the emptying opening (2) has a downwardly frustoconically flaring discharge hopper (4) into which the closure cover (6-9) can engage.
Patent AU-748471-B2 (AU)
Title: Data resampler for data processing system
Inventor: GREENBERG MICHAEL P
IPC: G06T3/00
Filed: 1998-11-12
Granted: 2002-06-06
Abstract: A data resampler for a data processing system for logically adjacent data samples includes a memory subsystem (120a) for storing samples to be rendered, a digital differential analyzer (401) for generating an interpolation corner address for a set of interpolation fractions. The resampler also includes a fetch unit (402) which receives the interpolation corner address and generates four source addresses of samples to be fetched from the memory subsystem (120a). The resampler also includes a first FIFO memory (90d) for holding the generated interpolation fractions and a second FIFO memory (90a) for holding pixel data. The resampler further includes an interpolation unit (403), which computes rendered result pixels, assembles the result pixels into memory words, and outputs the words via a third FIFO memory (90c).
Patent AU-552497-B2 (AU)
Title: Reinforcing elastomeric article
Inventor: VANASSCHE ROGER
IPC: B65G15/34
Filed: 1983-05-31
Granted: 1986-06-05
Abstract: A flat reinforcing structure for elastomeric objects such as conveyor belts comprises a first series of parallel cords covered on one side by a second series of parallel cords which with respect to the first series are transversely disposed and whereby the cords are mutually connected at the intersections. The nominal tensile strength of the first series of cords per unit width is at least twice the nominal tensile strength of the second series of cord per unit width. The tensile strength of each cord of the first series is at least one and at most ten times the tensile strength of each of cord of the second series. The cords are preferably steel cords.
Patent AU-705648-B2 (AU)
Title: System for inserting material into corneal stroma
Inventor: MATHIS MARK L
IPC: A61F9/007
Filed: 1995-01-06
Granted: 1999-05-27
Abstract: This invention is an improved method and kit for producing a desired channel or pathway in the interlamellar space in the corneal stroma for inserting a biocompatible material. The biocompatible polymer may be an intrastromal corneal ring (ICR). The method involves the use of clockwise and counter-clockwise dissectors, and optionally channel connectors and finish channel connectors. The kit contains clockwise and counter-clockwise dissectors and optionally channel connectors, finish channel connectors and probes.
Patent AU-688505-B2 (AU)
Title: Palladium catalyzed ring closure of triazolyl tryptamine
Inventor: CHEN CHENG Y
IPC: C07D403/06
Filed: 1995-05-19
Granted: 1998-03-12
Abstract: A new process is described for the synthesis of the triazolyl tryptamine:   <IMAGE>   and related compounds. The process involves a palladium-catalyzed ring closure between a substituted ortho-iodoaniline and a protected 1-alkynol. The process is carded out at high temperature, e.g. 100 DEG  C., in a dry inert solvent, e.g., DMF and in the presence of a proton acceptor, e.g., Na2CO3 or a trialkylamine. The triazolyl tryptamine, as well as acid addition salts thereof, is a 5 HT1D receptor agonist having anti-migraine properties.
Patent AU-679427-B2 (AU)
Title: DNA sequences encoding gelonin polypeptide
Inventor: ROSENBLUM MICHAEL G
IPC: C12N15/70
Filed: 1992-08-21
Granted: 1997-07-03
Abstract: The present invention provides the nucleotide sequence for a synthetic gene for the plant toxin gelonin and a process for producing, cloning and expressing this synthetic gene. The DNA sequence for a synthetic gene for gelonin as shown in sequence ID NO. 1. The present invention also provides expression vectors containing the DNA sequences for gelonin and cells transformed with these vectors. In addition, an immunotoxin comprising an antibody of conjugated to the protein gelonin.
Patent AU-778953-B2 (AU)
Title: Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
Inventor: MARTINEZ GERARD
IPC: A61K8/00
Filed: 2000-12-20
Granted: 2004-12-23
Abstract: The use of compositions containing a polysaccharide (I) having 3 - 5 oside units and at least one D-galactose unit linked by an alpha -1-6 bond to a sucrose unit, and a second compound (II) that is positively charged at physiological pH and stimulates pinocytosis or stimulates membrane penetration. The polysaccharide is of formula (I) [Image] R 1 - R 4H, 1-10C alkyl that may be unsaturated, 1-10C acid function that may be unsaturated, a sulfate, or a sugar. (I) is preferably raffinose or stachyose, or their derivatives. The second compound (II) is preferably a saponin or arginine. The concentration of (I) in the compositions is preferably 0.01 - 20% by weight, and that of (II) is preferably 5 - 20% of the weight of (I). ACTIVITY : Antiallergic, Antiinflammatory; Antiasthmatic; Dermatological; Ophthalmological; Antipruritic; Antipsoriatic. MECHANISM OF ACTION : Anti-IgE, anti-substance P.
Patent AU-771496-B2 (AU)
Title: Improved hair styling method
Inventor: HIRATA YOSHIHIRO
IPC: A45D7/00
Filed: 2001-01-18
Granted: 2004-03-25
Abstract: The health condition of client's hair is thoroughly understood prior to hair treatment by diagnosing the extent of damage in terms of perming, coloring, straightening, frequency of shampooing, home care, use of hair care products, and the like so that the most appropriate preparatory treatment, necessary softening time, liquid chemical, reaction time with liquid chemical, and ironing temperatures are determined according to the extent of damage to carry out a hair treatment procedure such as perming and coloring. <IMAGE>
Patent AU-750579-B2 (AU)
Title: 20-HETE antagonists and agonists
Inventor: ROMAN RICHARD J
IPC: A61P9/08
Filed: 1999-02-24
Granted: 2002-07-25
Abstract: 20-HETE agonists and antagonists are disclosed along with therapeutic applications. In a preferable form of the invention, the 20-HETE agonists are selected from the group consisting of 21-hydroxyheneicosa-5(Z),8(Z),11(Z),14(Z)-tetraenoic acid, 20-hydroxyeicosa-5(Z),4(Z)-dienoic acid and 20-,21-dimethyl 20-HETE. Preferable 20-HETE antagonists include 5(S)-HETE, 15(S)-HETE, 19(S)-HETE, 19-hydroxynonadeca-5(Z),8(Z),ll(Z),14(Z)-tetraenoic acid and 20-hydroxyeicosa 6(Z),15(Z)-dienoic acid.
Patent AU-699460-B2 (AU)
Title: Dressing
Inventor: WARD WILLIAM JOHN
IPC: A61L15/54
Filed: 1995-07-03
Granted: 1998-12-03
Abstract: There is described a tungsten loaded radiopaque adhesive and radiopaque dressings which are detectable by x-ray scanning, and processes for their manufacture.
Patent AU-734726-B2 (AU)
Title: Ozone applications for disinfection, purification and deodorization
Inventor: MALKIN BORIS
IPC: B82B1/00
Filed: 1997-06-26
Granted: 2001-06-21
Abstract: A frame-type ozone generator (242) has a plurality of elongated electrodes (201, 202) deployed in substantially parallel, spaced relation to each other so as to form a substantially flat electrode array, and a flow generator (241) for generating a flow of oxygen containing gas through the electrode array in a direction substantially perpendicular to the electrode array. Each of the electrodes is formed from an electrically conductive core (211) covered with polyvinyl-difluoride (212). Preferably, each electrode array is arranged within a frame (206) of a given area. Also disclosed are an apparatus for treating a product with ozone-containing gas in which pressure-waves are used to enhance effectiveness of the ozone treatment, and a two-chamber batch method for implementing treatment of a product with possibly harmful gases such as ozone.
Patent AU-613734-B2 (AU)
Title: Method for treating hyperuricemia
Inventor: NAKAMOTO KOUJI
IPC: A61K31/165
Filed: 1989-04-07
Granted: 1991-08-08
Abstract: Hyperuricemia is prevented, improved and treated with N-(3-(4 min -(2 sec ,6 sec -dimethylheptyl)phenyl)butanoyl)ethanolamine. <CHEM> m
Patent AU-662202-B2 (AU)
Title: Polyolefin compositions having good transparency and impact resistance
Inventor: GHISELLINI RENATO
IPC: C08L23/10
Filed: 1993-02-17
Granted: 1995-08-24
Abstract: Polyolefin compositions having good transparancy and impact resistance even at low temperatures comprising (by weight):   A) from 25 to 95 parts of a crystalline random copolymer of propylene with ethylene and/or another  alpha -olefin, containing more than 85% by weight of propylene, and having Haze values lower than 25%; and B) from 5 to 75 parts of a component comprising (a) an elastomeric copolymer of ethylene with propylene and/or another  alpha -olefin, and optionally with minor proportions of a diene, containing 20-80 parts of ethylene, and (b) one or more of the polymers selected from LLDPE, LDPE, HDPE, having a Melt Index higher than 0.5 g/10 min., said (a) and (b) being present in such proportions that the ratio between the density of (A) and calculated average density of (B) is from 0.980 to 1.015. i
Patent AU-616530-B2 (AU)
Title: Data path protection
Inventor: FERGUSON STEPHEN PATRICK
IPC: H04L1/22
Filed: 1989-06-08
Granted: 1991-10-31
Abstract: The invention concerns a transmission system in which a plurality of data streams are to be multiplexed and sent between receiving and transmitting equipment. At the transmit end the system comprises a plurality of worker tributary cards (51, 52) each having an input port (57) connected to an individual tributary to be sent to an associated multiplexer, and a stand-by tributary card (56) operative to replace a failed worker card. All the worker tributary cards (51 - 55) are interconnected by a common line (60) leading to the input port (57) of the stand-by tributary card (56) but in normal operation being isolated from said line by a controllable unity-gain buffer 58. Each tributary to be transmitted is connected to an input port (57) of a worker tributary card and has a branch line which is connected to said common line (60) via the buffer (58) carried on another tributary card, detection of failure of a worker tributary causing the buffer (58) of the associated worker tributary card to be enabled to connect the tributary to said stand-by tributary card.
Patent AU-566974-B2 (AU)
Title: Pharmaceutical preparations containing a phospholipidan an oxicam derivative
Inventor: WENDEL ARMIN
IPC: A61K45/06
Filed: 1984-12-14
Granted: 1987-11-05
Abstract: Pharmaceutical preparation containing phospholipids for the therapeutic treatment of rheumatic diseases which contain in addition to the antiphlogistically acting oxicam derivatives of the general formula   <IMAGE>   special 1,2-diacyl-glycero-3-phosphocholines wherein 75-86% by weight of the acyl radicals are unsaturated fatty acid radicals, and the preparation thereof.
Patent AU-757965-B2 (AU)
Title: 4,4-diarylbutadienes as water-soluble photostable UV filters for cosmetics and pharmaceutical preparations
Inventor: HABECK THORSTEN
IPC: C07C69/734
Filed: 1999-06-25
Granted: 2003-03-13
Abstract: 4,4-Diarylbutadienes (I) are new. Diaryl-butadienes of formula (I) (where the diene system is in Z,Z, E,Z, Z,E or E,E configuration, or a mixture of these) are new: R1, R2 = H; 1-20C alkyl, 2-10C alkenyl, 3-10C cycloalkyl, 3-10C cycloalkenyl, 1-12C alkoxy, 1-20C alkoxycarbonyl, mono- or di-(1-12C alkyl)-amino, aryl or heteroaryl (optionally substituted); or water-solubilizing substituents selected from carboxylate, sulfonate and ammonium groups; R3 = H, COOR5, COR5, CONR5R6 or CN; R4 = COOR6, COR6 or CONR5R6; R5 = H, -(X)o-R7 or -(1-6C) alkylene-Q; Q = SO3Y, PO3Y or N<+)<R8)3.A<->; R6 = as R5 but not H; X = (CH2)pZ, CHMeCH2Z or CH2CHEtZ; p = 2-4; A = Cl, Br, I or SO4R9; Y = H, Na<+>, K<+>, Mg<2+>, Ca<2+>, Li<+>, Al<3+> or N(R8)4<+>; Z = O or NH; R7, R8 = H, 1-8C alkyl, 2-6C alkenyl or 1-6C acyl; R9 = H, 1-6C alkyl or 2-6C alkenyl; n = 1-3; and o = 1-150.
Patent AU-716319-B2 (AU)
Title: The preparation of 3-pyrroline-2-carboxylic acid derivatives
Inventor: MACK HELMUT
IPC: C07D401/12
Filed: 1997-07-14
Granted: 2000-02-24
Abstract: PCT No. PCT/EP97/03752 Sec. 371 Date Jan. 22, 1999 Sec. 102(e) Date Jan. 22, 1999 PCT Filed Jul. 14, 1997 PCT Pub. No. WO98/04523 PCT Pub. Date Feb. 5, 19983-Pyrroline-2-carboxylic acid derivatives of the formula I are prepared by eliminating the sulfonic acid residue, with the aid of a base, from a compound of the formula II
Patent AU-781103-B2 (AU)
Title: Zinc finger domains and methods of identifying same
Inventor: KIM JIN-SOO
IPC: C12Q1/68
Filed: 2001-02-17
Granted: 2005-05-05
Abstract: Disclosed is an in vivo selection method for identifying zinc finger domains that recognize any given target site. Also disclosed are the amino acid sequences of zinc finger domains that recognize particular sites.
Patent AU-752404-B2 (AU)
Title: Dyeable fluoropolymer fibers and films
Inventor: UY WILLIAM CHENG
IPC: D01F6/48
Filed: 1999-05-26
Granted: 2002-09-19
Abstract: This invention relates to fluoropolymer fibers and films which can be modified by cationic agents, such as cationic dyes. The fiber or film comprises a blend of a first and a second copolymer, or it comprises a terpolymer, the blend or terpolymer having (1) an acid or ionic functionality provided by a pendant group represented by the formula -(O-CF2CFR)aO-CF2CFR'SO3-Z+, wherein R and R' are independently selected from F, Cl or a perfluorinated alkyl group having 1 to 10 carbon atoms, a=0, 1 or 2, and Z+ is H+, an alkali metal cation, or a cation derived from a compound selected from the group consisting of a cationic dye, a cationic whitener, a cationic flame retardant, a cationic antistatic agent, and mixtures thereof, and (2) a larger amount of a fluoroalkylvinylether, a fluoroalkene, or ethylene functionality. Such fibers and films are useful in various consumer goods where the product is desirably colored, whitened, antistatic, or flame retardant.
Patent AU-775166-B2 (AU)
Title: Selective NPY (Y5) antagonists
Inventor: MARZABADI MOHAMMAD R
IPC: A61P9/04
Filed: 2000-04-21
Granted: 2004-07-22
Abstract: This invention is directed to triazine derivatives, bicyclic compounds and tricyclic compounds which are selective antagonists for a NPY (Y5) receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of this invention and a pharmaceutically acceptable carrier. This invention provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The invention further provides the use of a compound of the invention for the preparation of a pharmaceutical composition for treating an abnormality, wherein the abnormality is alleviated by decreasing the activity of a human Y5 receptor.
Patent AU-580086-B2 (AU)
Title: New steroids substituted at position 10 by a radical including a double or triple bond, their preparation process, their use as medicaments, pharmaceutical compositions containing them
Inventor: TORELLI VESPERTO
IPC: C07J41/00
Filed: 1985-08-23
Granted: 1988-12-22
Abstract: The intermediate products of formula (II): <IMAGE> R' = especially H or optionally substituted alkyl, alkenyl, alkynyl, aryl or aralkyl, hydroxyl, tetrahydropyranyl, tert-butoxy, optionally esterified carboxyl, amino, mono- or dialkylamino, tritylamino, chloroacetamido, trifluoroacetylamino, trichloroethoxycarbonylamino, halogen or trialkylsilyl, R2 = methyl or ethyl, and process for their preparation.
Patent AU-755280-B2 (AU)
Title: Method for purifying hemoglobin
Inventor: HOUTCHENS ROBERT A
IPC: A01N1/02
Filed: 1999-06-21
Granted: 2002-12-05
Abstract: A method for producing a purified hemoglobin product includes loading a hemoglobin solution onto an anion exchange chromatography column. At least one tris(hydroxymethyl) aminomethane acetate buffer solution is injected into the column. The buffer solution has a pH lower than that of the column, whereby a purified hemoglobin product elutes from the column. In one embodiment, the hemoglobin solution initially can be equilibrated at a pH of greater than about 8.7. In another embodiment, contaminants can be removed by equilibrating the column with at least about eleven column void volumes of buffer solution at an intermediate pH of between about 8.2 and about 8.6, to thereby form a stepped pH gradient. In still another embodiment, all buffer solutions employed are tris(hydroxymethyl) aminomethane acetate.
Patent AU-583537-B2 (AU)
Title: Thiazolidinedione derivatives, their production and use
Inventor: MEGURO KANJI
IPC: C07D333/00
Filed: 1985-10-01
Granted: 1989-05-04
Abstract: Thiazolidinedione derivatives of the general formula: <CHEM> [wherein R<1> is hydrogen or a hydrocarbon residue or heterocyclic residue which may each be substituted; R<2> is hydrogen or lower alkyl which may be substituted by hydroxyl group; X is an oxygen or sulfur atom; Z is a hydroxylated methylene or carbonyl; m is 0 or 1; n is an integer of 1 to 3; L and M represent independently a hydrogen atom or L and M combine with each other to cooperate jointly to form a linkage] and their salts, which are novel compounds, possess blood-glucose and blood-lipid lowering actions in mammals, and are of value as a therapeutic agent for diabetes and therapeutic agent for hyperlipemia.